bibliographic entry 679261 [be/679261]
https://w3id.org/oc/corpus/be/679261

is a

• bibliographic reference

content

• Charokopou, M, McEwan, P, Lister, S. Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to metformin in the treatment of type 2 diabetes mellitus from a UK healthcare system perspective, BMC Health Serv Res, 2015, 15, 496, PMID: 26541516

references

• https://w3id.org/oc/corpus/br/1038281